Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
QMRO Home
William Harvey Research Institute
Centre for Clinical Pharmacology
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
QMRO Home
William Harvey Research Institute
Centre for Clinical Pharmacology
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
View/
Open
Published version (202.5Kb)
Volume
5
DOI
10.1371/journal.pgen.1000433
Journal
PLOS GENETICS
Issue
3
ISSN
1553-7404
Metadata
Show full item record
Authors
Takeuchi, F; McGinnis, R; Bourgeois, S; Barnes, C; Eriksson, N; Soranzo, N; Whittaker, P; Ranganath, V; Kumanduri, V; McLaren, W
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/19449
Collections
Centre for Clinical Pharmacology
[1083]
Licence information
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Copyright statements
(c) 2009 Takeuchi et al.